Department of Medicine

Research Faculty

Cardiology	Endocrinology & Metabolism	Nephrology
Clinical Immunology & Allergy	Gastroenterology	Neurology
Clinical Pharmacology & Therapeutics	Geriatrics	Physical Medicine & Rehabilitation
Critical Care	General Internal Medicine	Respirology
Dermatology	Hematology & Thromboembolism	Rheumatology
Emergency Medicine	Infectious Diseases

Cardiology

Jeff Healey MD, MSc
Prevention of atrial fibrillation and stroke through modification of risk factors. Clinical trials of cardiac pacemakers and implantable defibrillators. Global registry of patients with atrial fibrillation.

Eva Lonn MD, MSc, FRCPC, FACC
Clinical trials in the primary and secondary prevention of cardiovascular diseases, vascular imaging in atherosclerosis, the study of traditional and emerging cardiovascular risk factors, cardiovascular epidemiology and the use of echocardiographic methods for the assessment of left ventricular mass and left ventricular systolic and diastolic function.

Omid Salehian MSc, MD, FRCPC, FACC, FAHA
Research interests in congenital heart disease, pregnancy and heart disease and echocardiography.

Frederick Spencer MD, FRCPC
Epidemiology of arterial and venous thrombotic diseases with a specific focus on utilization of evidence-based therapies.

Koon Teo MBBCh, PhD, FRCPC, FRCPI, FACC, FAHA
Origins of atherosclerosis and cardiovascular risk factors in early life; influences of environmental and genetic factors in future cardiovascular disease.

Clinical Immunology & Allergy

Michael Cyr MSc, MD
Research interest in birth cohorts and cord blood stem cells

Judah Denburg MD, FRCPC
Developmental biology of eosinophils, basophils and mast cells, and their regulation in allergic inflammation

Paul Kevin Keith MD, MSc
Research interest in outcomes assessment for allergic and clinical immunology conditions particularly asthma, rhinitis, and nasal polyposis

Maggie J Larché MRCP(UK), PhD
Research interests in biomarkers in inflammatory arthritis, particularly imaging (MRI and ultrasonography) and cytokines.

Mark Larché PhD
Immunopathogenesis and immunotherapy of allergic, autoimmune and transplantation-related diseases

Susan Waserman MSc, MD, FRCPC
Research interests include food related anaphylaxis, as well as clinical trials in a variety of therapeutic areas related to rhinitis and asthma

Clinical Pharmacology & Therapeutics

Dr. Lisa Dolovich MSc, PharmD
Research focuses on evaluating the clinical and policy relevance of interventions that can improve prescribing practices and patient medication-taking behaviour. Leads the Medication Safety and Effectiveness team.

Dr. Anne Holbrook MD, PharmD, MSc, FRCPC
Drug policy interventions, prescribing decision support for patients and providers, the individualization of benefit:harm information for patients, improving quality of drug therapy trials, observational studies and economic analyses. Leads eHealth research team.

Dr. Mitchell Levine MD, MSc, FRCPC
Assessing prescription drug use in the community and developing methods for promoting cost-effective use of drug therapy.

Dr. Dan Perri BScPhm, MD, FRCPC
Appropriate use of medications in critical illness, medication safety and error reduction strategies, and the safe use of natural health products in concert with medications.

Dr. Rolf Sebaldt MD, CM, FRCPC, FACP
Designing and performing observational and interventional studies focused on evaluating and improving appropriate drug prescribing as well as designing and implementing novel and scalable information technology-based solutions to improve clinical data capture.

Critical Care

Deborah Cook MD, FRCPC, MSc (Epid), DABIM
Designs and conducts clinical trials, systematic reviews and knowledge translation for the critically ill

Andreas Freitag MD, FRCPC, FCCP
Clinical trials in critical care and cystic fibrosis

Alison Fox-Robichaud MD, MSc, FRCPC
In vivo responses associated with gastrointestinal inflammation, septic shock and fluid resuscitation

Maureen Meade MD, FRCPC, MSc (Epid)
Designs and conducts clinical trials, systematic reviews on acute lung injury and ventilatory strategies

Roman Jaeschke MD, MSc (Epid), FRCPC
Practice guidelines development, quality of life measurement and EBM teaching concepts

Tim Karachi MD, FRCPC
Clinical trials in critical care

Dermatology

Channy Muhn MD, FRCPC
Photodynamic therapy, focused ultrasound technology, laser and injectables soft tissue fillers

Nathan Rosen MD, FRCPC
Photodynamic therapy, focused ultrasound technology, laser and injectables soft tissue fillers

Peter Vignjevic MD, FRCPC
Psoriasis therapy, acne therapy

Emergency Medicine

Dr. Jonathan Sherbino, MD, MEd, FRCPC
Cognitive bias in clinical decision-making and knowledge translation for clinical practice.

Andrew Worster, MD, MSc, CCFP(EM), FCFP
Knowledge translation optimization of the most clinically relevant and current information for practicing emergency physicians wordwide.

Endocrinology & Metabolism

Hertzel C. Gerstein MD, MSc, FRCPC
Epidemiologic study of the relationship between dysglycemia, diabetes and cardiovascular disease, clinical trials in diabetes prevention and therapy.

William Harper MD, FRCPC, ABIM
Clinical trials on diabetes mellitus, cardiovascular disease, and benign thyroid goitre. Observational and quality assurance projects on inpatient management of diabetes mellitus.

Gianluca Iacobellis MD, PhD
Diagnostic, pathogenic and cardiovascular aspects of obesity and metabolic syndrome, epicardial adipose tissue projects.

Aliya Khan MD, FRCPC, FACP, FACE
Osteoporosis and parathyroid disease, primary hyperparathyroidism, osteonecrosis of the jaw, diagnosis of bone strength and assessment of bone quality.

Ally Prebtani BScPhm, MD, ABIM, FRCP(C)
Diabetes mellitus and cardiovascular disease

Zubin Punthakee MD, MSc, FRCPC, ABIM
Clinical trials of diabetes management and prevention; association between obesity and insulin resistance/diabetes, especially in youth; health care delivery and outcomes during transition from pediatric to adult care.

Gregory Steinberg PhD
Understanding the causes of inflammation and insulin resistance in obesity as it relates to the development of type 2 diabetes and cardiovascular disease; identifying the molecular events which lead to the insulin sensitizing effects of exercise.

Gastroenterology

David Armstrong MA, MB BChir, FRCPC, FRCP(UK), FACG, AGAF
Upper gastrointestinal diseases including gastroesophageal reflux disease (GERD), Barrett’s esophagus, Helicobacter pylori-related disease and dyspepsia, nutrition, including home parenteral nutrition, practice audit and education in endoscopy

Premysl Bercik MD
Functional gastrointestinal diseases, gastrointestinal motility, visceral sensitivity, gut-brain axis

Stephen Collins MBBS, FRCP(UK), FRCPC
Immune modulation of enteric nerve and muscle function

Subhas Ganguli MD MSc FRCPC
Clinical studies in functional gastrointestinal disorders

Jan Huizinga PhD
Physiology and pharmacology of gastrointestinal function, in particular the electrophysiology of gastrointestinal smooth muscle

Richard Hunt FRCP, FRCP(Edin), FRCPC, FACG
Pathophysiology of acid-related disorders, clinical pharmacology of treatment of gastrointestinal disease

Waliul Khan MBBS, PhD
Mucosal immunology, immuno-physiology and host defense in the context of intestinal infection/inflammation

Grigorios Leontiadis MD, PhD
Systematic review, evidence based medicine, upper gastrointestinal bleeding, Helicobacter pylori

John Marshall MD, MSc, FRCPC, AGAF
Clinical studies in inflammatory bowel disease, clinical outcomes research

Kathy McCoy PhD
Mucosal immunology, development of the immune system, allergic disease

Paul Moayyedi MB ChB, PhD, MPH, FRCP (London), FRCPC, FACG, AGAF
Gastroenterology health services research

David Morgan MD, MSc, FRCPC
Clinical gastroenterology research related to NSAID injury

Robert Spaziani MD, FRCP(C)
Clinical studies in functional gastrointestinal disorders

Frances Tse MD, FRCPC
Endoscopy related research, quality in endoscopy

Keith Tsoi MD, FRCPC
Clinical trials in hepatology

Elena Verdú MD, PhD
Pathogenesis of chronic inflammatory disorders such as celiac disease; host-bacterial interactions, in particular in the context of probiotics and functional gastrointestinal diseases

John Wallace PhD, MBA, FRSC
Inflammation and its impact on gastrointestinal tissue injury and repair

Geriatric Medicine

David Cowan BaH, MIR, MD, FRCP(C)
Research interest lies in the interaction between frailty and the chronic management of heart disease in aging persons.

George Heckman MD, MSc, FRCPC
Interaction between frailty and the chronic management of heart disease in aging persons.

Brian Misiaszek MD, FRCPS (C)
Medication optimization in the elderly; evidence for outreach (home visits) in Geriatrics.

D.W. Molloy MB, MRCPI, FRCPC
Treatment of dementia by the antibiotics doxycycline and rifampicin as well as issues of capacity and decision-making among the elderly.

Alexandra Papaioannou MD, MSc, FRCP(C), FACP
Osteoporosis and fracture prevention; appropriate prescribing in long-term care.

Christopher Patterson MD, FRCPC, FACP, FRCP (Glasg)
Preventive health care and cognitive disorders in aging persons.

General Internal Medicine

Jan Brozek MD, PhD
Clinical practice guidelines methodology; systematic reviews and development of clinical practice guidelines in allergy and immunology; knowledge translation.

James Douketis MD
Perioperative anticoagulant and antiplatelet therapy, prognosis of venous thromboembolism, risk factors for anticoagulant-related bleeding, deep vein thrombosis prophylaxis in hospitalized medical patients, hormonal therapy and VTE, prevention and treatment of obesity, clinical practice guidelines.

Gordon Guyatt MD, MSc, FRCPC
Dissemination of concepts of evidence-based medicine to health workers and health-care consumers; measurement of health-related quality of life; clinical trials and overview methodology; medical decision-making.

R. Brian Haynes MD, MSc, PhD, FRCPC, FACMI
Knowledge translation research and medical informatics, focused on ways to improve medical care through improving the dissemination and application of validated medical care knowledge. For more information visit HIRU

Dereck Hunt MD, MSc, FRCP(C)
Medical informatics and diabetes care; foot complications in diabetes mellitus; clinical practice guidelines for diabetes care.

Akbar Panju MB ChB, FRCP(C), FRCP (Edin)
Clinical cardiology with a particular focus in etiology of chest pain of non-cardiac origin and patients with normal coronaries; hypertension research; clinical thrombosis with use of newer anticoagulants; etiology and treatment of post-stroke central pain.

Ameen Patel MB, FRCP(C), FACP
Evaluation of diagnosis, treatment and risk of recurrence of venous thromboembolism (VTE) in medical and surgical populations. Examination of the prevalence of VTE in hospitalized medical patients and the use of published guidelines for prevention of VTE in this population.

Holger Schunemann MD, PhD, MSc, FRCP(C)
Guideline development; systematic reviews; respiratory function epidemiology; health related quality of life; co-chair of the international GRADE working group, which developed a common system for grading the quality of evidence and strength of recommendations in healthcare.

John You MD, MSc, FRCPC
Evaluation of benefits, harms, and appropriateness of diagnostic imaging; colorectal cancer screening; clinical practice guidelines for stroke prevention in atrial fibrillation.

Hematology & Thromboembolism

Donald M. Arnold MD, MSc, FRCP(C)
Platelet disorders with a focus on clinical trials, optimal use of platelet transfusions in critically ill patients. Spearheading a new Canadian multi-centered pilot trial of rituximab in ITP.

Shannon Bates MDCM, MSc, FRCP(C)
The role of D-dimer testing in patients with suspected recurrent deep vein thrombosis, evaluating a new diagnostic strategy in suspected pulmonary embolism.

Howard H.W. Chan MBChB, MSc, FRCP(C)
Pathophysiology of thromboembolism, focusing on the interactions of fibrinogen with divalent cations and other proteins.

Mark Crowther MD, MSc, FRCPC
Use of vitamin K to treat warfarin-associated coagulopathy, use of low molecular weight heparin in renal failure, blood clotting complications in end-stage renal disease.

James Douketis MD
Perioperative antithrombotic therapy, bleeding and risk factors for bleeding during antithrombotic therapy, hormonal therapy and thrombosis.

John Eikelboom MBBS, MSc, FRACP, FRCPA
Mechanisms and genetic determinants of antiplatelet drug resistance and improving its diagnosis and treatment.

Jeff Ginsberg MD, FRCPC
Thromboembolic disease, diagnosis and management

Peter L. Gross MD, MSc, FRCPC (C)
Cell-adhesion molecule control of fibrin in a thrombus, statin inhibition of platelet function, and antithrombin in the sepsis syndrome.

Catherine P.M. Hayward MD, PhD, FRCP(C)
Blood clotting and vascular repair, leading to discover of new protein, multimerin 1 and Quebec Platelet Disorder.

Nancy Marie Heddle MSc, FCSMLS(D)
Adverse effects to blood transfusion, determining the optimal dose for platelet transfusion, optimal blood utilization practices, transfusion issues in neonates and cardiovascular patients.

Clive Kearon MD, MRCPI, FRCPC, PhD
Diagnosis and treatment of venous thromboembolic disease, the ability of D-dimer blood test results to exclude the presence of deep vein thrombosis and pulmonary embolism.

John Kelton MD, FRCPC
Mechanisms of immune protection and trafficking of autoantibodies in platelets. Pathophysiology of heparin-induced thrombocytopenia and analysis of determinants and factors responsible for clinical outcome.

Brian Leber MD
Basic biochemical mechanisms in apoptosis

Patricia Liaw BSc, MSc, PhD
Mechanistic links between coagulation, inflammation, and apoptosis, particularly those associated with the pathophysiology of sepsis and chemotherapy-induced thrombogenesis.

Wendy Lim MD, MSc, FRCP(C)
Thrombotic disease and anticoagulant use in patients with renal insufficiency and the significance of elevated cardiac troponin in critically ill patients.

Lori-Ann Linkins MD, FRCP(C)
Clinical diagnosis of deep vein thrombosis, bleeding on anticoagulant therapy, and diagnosis of heparin induced thrombocytopenia.

Martin O’Donnell MB, MRCPI
Evidence-based medicine and vascular disease, particularly in the areas of stroke and venous thrombosis.

Sam Schulman MD, FRCPC(C)
Clinical studies in venous thromboembolism including novel agents.

Fred Spencer MD
Understanding of the current profile of patients at risk for arterial and venous disease and their complications.

Irwin Walker MBBS, FRACP, FRCPC
Development of hemophilia related software programs, the Canadian Hemophilia Registry, and epidemiological data relating to hemophilia.

Kathryn E. Webert MD, FRCPC
Role of hemoglobin level on the frequency of bleeding in patients with acute leukemia and patients undergoing stem cell transplantation.

Jeffrey Weitz MD FRCP(C), FACP
Basic mechanisms by which anticoagulants and thrombolytic agents work, specific molecular changes that take place in blood vessel walls and give rise to thrombosis.

Geoffrey Werstuck PhD
Mechanisms by which diabetes promotes the development and progression of atherosclerosis.

Infectious Diseases

Philippe El-Helou MD, FRCPC
Novel drug therapies for HIV infection, co-infection of Herpes Simplex Virus and HIV

Shariq Haider MD, FRCPC, ABIM DTMH CCST
Novel antiretroviral therapy in naïve and experienced HIV infected patients, epidemiology, diagnosis and treatment of HCV co-infection in HIV infected patients, novel antifungal therapies in neutropenic hosts

Christine Lee MD, FRCPC
Optimal laboratory methods of diagnosis and treatment of Clostridium difficile-associated diarrhea; refining microbiologic diagnosis of STDs, and diagnosis and management of nosocomial infections

Mark Loeb MD, MSc, FRCPC
Epidemiologic and genomic population-based studies on viral infectious including influenza, West Nile, and dengue; a CIHR funded influenza pandemic team grant to establish natural history as well as immunologic and genetic determinants of influenza infection

Lionel Mandell MD, FRCPC, FRCP (Lond)
Studies of pneumonia, community acquired pneumonia and antibiotics

Atreyi Mukherji MD, FRCP(C), MPH
Research interest involves the social determinants of health in marginalized populations, affected by HIV and injection drug use

Nephrology

Diane Arlen BSc, MD, FRCP
Dr. Arlen leads a multicentre observational study investigating cardiovascular outcomes following renal transplantation (the SCORE study)

Richard Austin PhD
Amgen Chair in Nephrology Research
The overall goal of Dr. Austin’s research program is to better understand the underlying cellular stress pathways that mediate atherothrombotic disease, particularly in the setting of uremia.

Scott Brimble MD, BScH, MSc, FRCPC
Translational research on anaemia, abnormalities in muscle and exercise capacity in chronic renal insufficiency; impact of peritoneal membrane transport properties on PD patient outcomes

Euan Carlisle MD, FRCPC
Optimization of management of patients with advanced chronic renal insufficiency and on dialysis

Catherine M. Clase BA, MB, BChir, MSc (HRM), FRCPC, FASN
Community epidemiology of chronic renal insufficiency with particular interest in the development of screening strategies that ultimately prevent cardiovascular or renal morbidity or mortality; optimal use of anti-platelet medications and anticoagulants in patients with low glomerular filtration rate and on dialysis

Azim S. Gangji MD, MSc, BSc Pharm, FRCPC, FACP
Clinical research focus on volume assessment and the optimization of volume management in dialysis patients; educational research in the effects of case-based learning for postgraduates

Joan Krepinsky MSc, MD
Dr. Krepinsky's lab studies mechanisms involved in the development and progression of chronic kidney failure in 2 settings, hypertension and diabetes

Peter Margetts MD, PhD
Dr. Margett's lab studies fibrosis as it relates to both the peritoneum and chronic renal disease; adnoviral transfection is also a focus

Christian Rabbat MD, FRCPC
Prevention of bleeding complications in patients on dialysis; safe prevention of venous thromboembolism in patients with critical illness

Damu Tang PhD Mechanisms of progression of prostate cancer, and novel protein mediators of vascular lipid accumulation

Darin Treleaven MD, FRCPC
The use of clinical databases for research and quality assurance in renal transplantation

Neurology

Steven Baker, MSc, MD, FRCPC, CSCN
Pathophysiologic mechanisms underlying statin-associated neuromuscular toxicity.

John Bienenstock, CM, MD (Hon), FRCP, FRCPC, FRSC
Mechanisms of allergy, mucosal immunology, and the interactions between mast cells and other cells of the immune system with the nervous system.

Mark Kamath, PhD
Signal, pattern recognition, image processing in medicine with particular interests to heart rate variability signal, gastro esophageal evoked potentials and electroencephalogram.

Michael Mazurek, MD, FRCP(C)
Neuropsychiatric disease - basal ganglia and cortical change.

Wieslaw Oczkowski, MD, FRCP(C)
Trials of treatments of stroke; prevention of stroke.

Michel P. Rathbone, MD, CHB, PhD, FRCPC
The effects of extracellular non-adenine based purines.

Demetrios J. Sahlas, MSc, MD, FRCP(C), DABPN
Diagnosis and management of carotid artery disease, use of transcranial doppler (TCD) ultrasound in the prevention and treatment of cerebrovascular disease, cognitive and neuropathological correlates of chronic microvascular ischemic changes involving the periventricular and subcortical white matter.

Mark Tarnopolsky, MD, PhD, FRCPC
Assessment of pharmacologic, nutritional and exercise interventions as treatments for patients with neuromuscular and neurometabolic disorders.

John Turnbull, MD, PhD, FRCPC
Motor neuron diseases and education

Physical Medicine & Rehabilitation

Steven Baker, BEd, MSc, MD, FRCPC, CSCN
Pathophysiologic mechanisms underlying statin-associated neuromuscular toxicity as well as acquired and hereditary (CMT) disorders of the peripheral nervous system.

Sharon Grad, MD, FRCPC
Amputee and orthotics rehabilitation, Multiple Sclerosis rehabilitation, musculoskeletal rehabilitation.

David Harvey, MD, FRCPC
Musculoskeletal rehabilitation, rehabilitation of people with cancer especially related to functional outcomes following rehabilitation interventions.

Dinesh Kumbhare, MD, MSc, FRCP(C)
Research interests in soft tissue injuries and imaging modalities.

Kevin Letcher, BSc, MD, FRCP(C)
Clinical research in the areas of musculoskeletal and sports medicine, with specific interest in concussion and relationship of S100b with level of neurological injury.

Mark Tarnopolsky, BPE, MD, PhD, FRCP(C)
Research interests in therapies to enhance muscle function in people with acquired and genetic neuromuscular diseases and mitochondrial dysfunction.

Respirology

Chris Allen, MD, MA, MB, BCh, MRCP (UK), FRCPC
Gastro-esophageal reflux and chronic cough

Gerard Cox, MD, MB, FRCPCI, FRCPC
Bronchial thermoplasty, Pulmonary fibrosis, smooth muscle and neutrophil biology

Clive Davis, MD
Clinical trials in pulmonary hypertension

Myrna Dolovich, PEng (Elec)
Aerosol physics, aerosol deposition in lung, lung imaging, ciliary motility

Punginathn Dorasamy, MD
Clinical trials in pulmonary hypertension

Paul Forsythe, MSc, PhD
Gut-lung immune axis, neural regulation of immune responses, Mast cell biology

Andreas Freitag, BSc, MD, FRCPC, FCCP
Clinical trials in cystic fibrosis

Gail Marie Gauvreau, BSc, MSc, PhD
Mechanisms of allergic asthma, phase II clinical trials of biologics in asthma

George Heigenhauser, JF, BA, MSc, PhD
Skeletal muscle metabolism and exercise physiology

Mark Inman, MSc, PhD, MD
Animals models of allergic sensitization, mechanisms of airway hyperresponsiveness and airway remodelling

Luke Janssen, MSc, PhD
Airway smooth muscle biology, ionic regulation of airway hyperresponsiveness, isoprostane biology and vascular responsiveness

Neil Johnston, MSc
Epidemiology of exacerbations of asthma and COPD

Kieran Killian, MD
Mechanisms of dyspnoea in health and disease, exercise limitation

Martin Kolb, MD, PhD
Molecular mechanisms of pulmonary fibrosis and pulmonary hypertension, TGF-β signalling, clinical trials in pulmonary fibrosis

Renée Labiris, MSc, PhD
Molecular imaging of the airways and lung parenchyma, evaluation of aerosols

Mark Larché, PhD
Peptide immunotherapy for allergic airway diseases, Treg biology in asthma, vaccine development

Andrew McIvor, MD
Outcomes research in asthma and COPD, dissemination and implementation of guidelines

Parameswaran Nair, MD, PhD, FRCP, FRCPC
Non-invasive measurements of airway inflammation in clinical practice, mechanisms of specific types of bronchitis, targeted therapy of eosinophilic and neutrophilic bronchitis

Helen Neighbour, MB, BS, MRCP (UK)
Assessment of upper airway inflammation, peptide vaccines for allergic rhinitis

Paul O’Byrne, MB, BCh, BAO. MRCPI, FRCPI, FRCP(C), FCCP, FRCP
Mechanisms of allergic asthma and hyperresponsiveness, clinical trials in asthma

Malcolm Sears, MB, ChB, FRACP, FRCPC, FAAAAI
Epidemiology of asthma, birth-cohort studies of allergy and asthma

Roma Sehmi, PhD
Hematopoietic progenitor biology in allergic airway diseases

Martin Stampfli, PhD
Effects of cigarette smoke on innate imunity and allergic responses, smoking models of emphysema

David Todd, MD, FRCPC
Determinants of success of pulmonary rehabilitation, systemic inflammation in COPD, exercise physiology

Rheumatology

J. D. Adachi, MD, FRCPC
The structural analysis of bone and cartilage as measured by pQCT and pMRI. Quantitative and qualitative analysis of erosions in rheumatoid arthritis using pMRI. Analysis of data from the Canadian multicenter osteoporosis study, a study of 10,000 subjects followed for 10 years.

Karen Beattie, BSc, PhD
Research interests in osteoarthritis, osteoporosis and rheumatoid arthritis including imaging and analyses (MRI, pQCT, DEXA, X-ray), disease symptoms, quality of life, physical function and patient and physician education.

Raja Bobba, MC, Bsc, FRCPC, ABIM
Systematic lupus erythematosus and thrombosis.

Pauline Boulos, MD, MSc, FRCPC
Research interests in medical education, osteoarthritis and rheumatoid arthritis.

Alfred Cividino, MD, FRCPC, FACR
Research interests in medical education, clinical trials in advanced therapeutics in rheumatoid arthritis,inflammatory arthritis and osteoarthritis.

Rafat Faraawi, MD, FRCPC, FACP
Rheumatoid arthritis, osteoarthritis, osteoporosis.

Brian Hanna, MD, FRCPC, MB
Multidisciplinary team approach to educate and care for patients at the Rheumatology Day Hospital.

Lawrence Hart, MB, BCh, MSc, FRCPC, FACP
Critical appraisal of the medical literature, the validation of outcome measures in the rheumatic diseases, and the epidemiology and management of soft tissue injuries.

Elzbieta Kaminska, MD, FRCPC
Connective tissue disease, vasculitis, and scleroderma.

W.F. Kean, MB, ChB, MD(Glas), FRCP (Glas, Edin, & C)
Anti-rheumatic drug pharmacology and clinical actions, and osteoarthritis pain mechanisms.

Nadar Khalidi, MD, FRCPC, FACP, FACR
Vasculitis and scleroderma

Maggie Larché, MBChB, MRCP(UK), PhD
Early inflammatory arthritis: imaging (ultrasonography and MRI) and cellular biomarkers.

Rolf Sebaldt, MD, CM, FRCPC, FACP
Studies in therapeutic areas including osteoporosis, osteoarthritis, hypertension, hypercholesterolemia, psychiatry, venous thromboembolism, gastroenterology, dermatology, respiratory, dementia, geriatric pharmacology, vaccination, and cancer screening.

Saeed Shaikh, MD, FRCPC, FACP, FACR
Ankylosing spondylitis and seronegative forms of arthritis.